Back to Search Start Over

Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT

Authors :
Frankiewicz, Andrzej
Peczynski, Christophe
Giebel, Sebastian
Harrington, Alenca
Socié, Gerard
Niederwieser, Dietger
Scheid, Christoph
Bornhäuser, Martin
Kröger, Nicolaus
Elmaagacli, Ahmet
Afanasyev, Boris
Dreger, Peter
Rössig, Claudia
Blaise, Didier
Kratz, Christian
Yakoub-Agha, Ibrahim
Kremens, Bernhard
Niemeyer, Charlotte Marie
Wulf, Gerald
Blau, Igor
Source :
Frontiers in Immunology; 7/23/2020, Vol. 11, p1-10, 10p
Publication Year :
2020

Abstract

Acute graft-vs.-host disease (aGvHD) is one of the most frequent causes of transplant-related mortality (TRM) after allogeneic hematopoietic cell transplantation (alloHCT). Its treatment is complex and costly. The aim of this study was to retrospectively analyze the impact of country-specific socioeconomic factors on outcome of patients who experience severe aGvHD. Adults with hematological malignancies receiving alloHCT from either HLA-matched siblings (n = 1,328) or unrelated donors (n = 2,824) developing grade 3 or 4 aGvHD were included. In univariate analysis, the probability of TRM at 2 years was increased for countries with lower current Health Care Expenditure (HCE, p = 0.04), lower HCE as % of Gross Domestic Product per capita (p = 0.003) and lower values of the Human Development Index (p = 0.02). In a multivariate model, the risk of TRM was most strongly predicted by current HCE (HR = 0.76, p = 0.006). HCE >median was also associated with reduced risk of the overall mortality (HR 0.73, p = 0.0006) and reduced risk of treatment failure (either relapse or TRM; HR 0.77, p = 0.004). We conclude that country-specific socioeconomic factors, in particular current HCE, are strongly associated with survival of patients who experience severe aGvHD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Volume :
11
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
144787746
Full Text :
https://doi.org/10.3389/fimmu.2020.01537